Metacognitive Therapy, Fluvoxamine, or Combination Treatment in Obsessive-Compulsive Disorder: A randomized clinical trial
Not Applicable
- Conditions
- Obsessive-Compulsive Disorder.Obsessive-compulsive disorder
- Registration Number
- IRCT138811303372N1
- Lead Sponsor
- Research Council of the Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 19
Inclusion Criteria
(1) diagnosis of OCD according to DSM-IV-TR, (2) duration of the illness for at least 1 year, (3) age between 18 to 50. Exclusion criteria: (1) currently suicidal or psychotic, (2)have a personality disorder, neurological disease or substance abuse problem and other comorbid axis I disorders, (3) have been receiving other psychological treatment or pharmacotherapy during the previous month.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Global functioning. Timepoint: before treatment, every two weeks for 3 months, every 6 months for one years in follow up. Method of measurement: Scale.;Obsessive-compulsive symptoms severity. Timepoint: before treatment, every two weeks for 3 months, every 6 months for one years in follow up. Method of measurement: scale.;Depression severity. Timepoint: before treatment, every two weeks for 3 months, every 6 months for one years in follow up. Method of measurement: Inventory.;Anxiety severity. Timepoint: before treatment, every two weeks for 3 months, every 6 months for one years in follow up. Method of measurement: Inventory.;Stress severity. Timepoint: before treatment, every two weeks for 3 months, every 6 months for one years in follow up. Method of measurement: Scale.;Subjective distress. Timepoint: before treatment, every two weeks for 3 months, every 6 months for one years in follow up. Method of measurement: Scale.
- Secondary Outcome Measures
Name Time Method Metacognition components. Timepoint: before and after treatment. Method of measurement: inventory.